<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1933">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136001</url>
  </required_header>
  <id_info>
    <org_study_id>2021.09.10-02</org_study_id>
    <nct_id>NCT05136001</nct_id>
  </id_info>
  <brief_title>Characterizations of Gut Microbiota and Postoperative Sleep in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass</brief_title>
  <official_title>Characterizations of Gut Microbiota and Postoperative Sleep in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators designed a study to assess whether there is any change in gut microbiota&#xD;
      and postoperative sleep before and after heart valve surgery with cardiopulmonary bypass.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators designed a study to assess whether there is any change in gut microbiota&#xD;
      and postoperative sleep before and after heart valve surgery with cardiopulmonary bypass.&#xD;
      Firstly, this study aims to characterize the gut microbiota in patients with valve disease&#xD;
      treated with surgery. Secondly, it aims to evaluate microbiota and its influence on&#xD;
      postoperative sleep.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2021</start_date>
  <completion_date type="Anticipated">August 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>gut microbiota</measure>
    <time_frame>from baseline to postoperative 72 hours</time_frame>
    <description>This study will characterize the gut microbiota in one group of 36 patients before and after heart valve surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative sleep</measure>
    <time_frame>on the second postoperative night from 20:00 to 6:00</time_frame>
    <description>This study will characterize the postoperative sleep measured by polysomnography in one group of 36 patients after heart valve surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum metabolites</measure>
    <time_frame>from baseline to postoperative 72 hours</time_frame>
    <description>This study will characterize the serum metabolites in one group of 36 patients before and after heart valve surgery</description>
  </secondary_outcome>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Heart Valve Surgery</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>polysomnography</intervention_name>
    <description>Duration of sleep was collected with polysomnography on second postoperative night. (from 20:00pm to 06:00am).</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      gut microbiota and serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study will characterize the gut microbiota and serum metabolites in one group of 36&#xD;
        patients before and after heart valve surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ethnic Chinese;&#xD;
&#xD;
          -  Age, 18 to 65 years old;&#xD;
&#xD;
          -  Patients undergoing heart valve surgery with cardiopulmonary bypass&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperative Pittsburgh Sleep Quality Index global scores higher than 6&#xD;
&#xD;
          -  Cognitive difficulties&#xD;
&#xD;
          -  Partial or complete gastrectomy&#xD;
&#xD;
          -  Previous esophageal surgery&#xD;
&#xD;
          -  Previous treated by radiotherapy or surgery&#xD;
&#xD;
          -  Inability to conform to the study's requirements&#xD;
&#xD;
          -  Body mass index exceeding 30 kg/m2&#xD;
&#xD;
          -  Deprivation of a right to decide by an administrative or juridical entity&#xD;
&#xD;
          -  Ongoing participation or participation in another study &lt;1 month ago&#xD;
&#xD;
          -  Recent (&lt; 3 months prior) use of antibiotics, probiotics, prebiotics, symbiotics,&#xD;
             hormonal medication, laxatives, proton pump inhibitors, insulin sensitizers or&#xD;
             traditional Chinese medicine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenfei Tan, M.D.,Ph.D</last_name>
      <phone>024-83283100</phone>
      <email>winfieldtan@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 6, 2021</study_first_submitted>
  <study_first_submitted_qc>November 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Gut Microbiota</keyword>
  <keyword>polysomnography</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

